In The News Posted April 19, 2019 Share Posted April 19, 2019 SILVER SPRING, Md., April 19, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose. The ... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.